Colorectal tumors from patients with a germline pathogenic POLE variant (i.e., variant leading to loss of the proofreading function of the polymerase) are usually MSS [212], but germline variants in POLE were sometimes reported in patients with early-onset MSI/dMMR CRC and somatic variants in MMR genes [213]. The gene discussed is POLE; the disease is colorectal carcinoma.